Alaunos Therapeutics, Inc. TCRT
At closeNov 3, 2026, 5:16 PM EST
After hours · Nov 3, 5:16 PM ET
- YTD
- -42.41%
- 1 year
- -31.37%
- Market cap
- 6.40M
- Revenue (ttm)
- 7.00K
- EPS (ttm)
- -1.84
- Shares out
- 1.60M
- Forward P/E
- -3.25
- YTD return
- -42.41%
- 1-year return
- -31.37%
- Volume
- 283.59K
- Avg volume
- 7.54M
- Open
- 1.77
- Previous close
- 1.75
- Day's range
- 1.70 – 1.90
- 52-week range
- 0.74 – 4.36
- Beta
- -0.50
- Earnings date
- Apr 2, 2024
2Y -0.17 (-8.46%)
Key statistics
- Enterprise value
- 883.62K
- PEG ratio
- 0.00
- Price / sales
- 446.15
- Price / book
- 0.50
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- -11.83M
- Total cash
- 2.46M
- Total debt
- 0
- Return on equity
- -150.50%
- Short % of float
- 10.11%
- 50-day average
- 2.18
- 200-day average
- 6.90
Next earnings
Apr 2, 2024
Expected Apr 2, 2024. Consensus EPS estimate 0.00.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 14, 2024 | Sep 1, 2024 | 0.00 | -0.70 | — | — |
| Aug 14, 2024 | Jun 1, 2024 | 0.00 | -0.71 | — | — |
| May 15, 2024 | Mar 1, 2024 | 0.00 | -1.10 | — | — |
| Apr 2, 2024 | Dec 1, 2023 | -0.60 | — | — | — |
| Nov 14, 2023 | Sep 1, 2023 | -4.50 | -6.00 | -1.50 | -33.33% |
| Aug 14, 2023 | Jun 1, 2023 | -6.00 | -6.00 | 0.00 | 0.00% |
About Alaunos Therapeutics, Inc.
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive T-cell receptor (TCR) engineered T-cell therapies (TCR-T) to treat multiple solid tumor types. It develops Library TCR-T Cell Theraphy, which is in Phase I/II clinical trial for 12 TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancreatic, ovarian, and bile duct cancers. The company is also developing hunTR, a human neoantigen TCR discovery engine; and Sleeping Beauty Gene Transfer Platform, a non-viral genetic engineering technology. The company was founded in 2003 and is headquartered in Houston, Texas.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- alaunos.com
News
12 Health Care Stocks Moving In Friday's Intraday Session 
12 Health Care Stocks Moving In Monday's Pre-Market Session 
12 Health Care Stocks Moving In Friday's Intraday Session - 12 Health Care Stocks Moving In Friday's Pre-Market Session
Why Alcoa Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - 12 Health Care Stocks Moving In Thursday's After-Market Session
- 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- 12 Health Care Stocks Moving In Tuesday's After-Market Session
Why is Alaunos Therapeutics Stock Trading 200% Higher on Tuesday? 
Why is Alaunos Therapeutics Stock Trading 200% Higher on Tuesday?
Your note
Sign in to keep a note on TCRT — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BAFFA RAFFAELE | Officer | Stock Award(Grant) | May 16, 2021 | 280,645 |
| BOWDEN CHRISTOPHER J | Director | Stock Award(Grant) | Jun 21, 2022 | 44,167 |
| BOYLE KEVIN S. SR | Chief Executive Officer | Sale | Aug 31, 2023 | 798,236 |
| DE GROOT ELEANOR M | Officer | Sale | Dec 21, 2021 | 237,106 |
| HAGEN HEIDI | Director | Purchase | Sep 1, 2021 | 145,889 |
| HUANG JAMES Z | Director | Stock Award(Grant) | Jun 21, 2022 | 188,333 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| MSD Partners, L.P. | 6.31% | 101,010 | 197.01K | Sep 29, 2024 |
| Vanguard Group Inc | 2.83% | 45,348 | 88.45K | Sep 29, 2024 |
| Blackrock Inc. | 1.39% | 22,233 | 43.36K | Sep 29, 2024 |
| Geode Capital Management, LLC | 1.02% | 16,333 | 31.86K | Sep 29, 2024 |
| Morgan Stanley | 0.08% | 1,337 | 2.61K | Sep 29, 2024 |
| UBS Group AG | 0.06% | 1,028 | 2.00K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.60% | 25,676 | 50.08K | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 1.28% | 20,471 | 39.93K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.56% | 8,924 | 17.41K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.15% | 2,376 | 4.63K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.13% | 2,082 | 4.06K | Oct 30, 2024 |
| Dimensional ETF Tr-Dimensional U.S. Core Equity 2 ETF | 0.08% | 1,271 | 2.48K | Jul 30, 2024 |